Report Categories Report Categories

Report Categories

industry Category

All

Total: 1 records, 1 pages

Global Dihydropyridine Calcium Channel Blocker Production, Demand and Key Producers, 2022-2028

date 30 Sep 2022

date Pharma & Healthcare

new_biaoQian dihydropyridine calcium blocker production demand producers

Dihydropyridine (DHP) calcium channel blockers are derived from the molecule dihydropyridine and often used to reduce systemic vascular resistance and arterial pressure. Sometimes when they are used to treat angina, the vasodilation and hypotension can lead to reflex tachycardia, which can be detrimental for patients with ischemicsymptoms because of the resulting increase in myocardial oxygen demand. Dihydropyridine calcium channel blockers can worsen proteinuria in patients with nephropathy.

USD4480.00

Add To Cart

Add To Cart

Dihydropyridine (DHP) calcium channel blockers are derived from the molecule dihydropyridine and often used to reduce systemic vascular resistance and arterial pressure. Sometimes when they are used to treat angina, the vasodilation and hypotension can lead to reflex tachycardia, which can be detrimental for patients with ischemicsymptoms because of the resulting increase in myocardial oxygen demand. Dihydropyridine calcium channel blockers can worsen proteinuria in patients with nephropathy.

USD4480.00

addToCart

Add To Cart